Lower Insulin Secretion is Associated with Hippocampal and Parahippocampal Gyrus Atrophy in Elderly Patients with Type 2 Diabetes Mellitus

Overview

Journal J Diabetes Investig

Specialty Endocrinology

Date 2021 Mar 30

PMID 33783982

Citations 7

Authors

Yuko Adachi

Kazuki Ota

Isao Minami

Tetsuya Yamada

Takayuki Watanabe

Affiliations

Soon will be listed here.

Abstract

Aims/introduction: We aimed to examine the association between diabetes-related parameters and hippocampal and parahippocampal gyrus atrophy (HPGA) in patients with type 2 diabetes mellitus to elucidate the risk factors for HPGA, which is often accompanied by Alzheimer's disease.

Materials And Methods: A total of 137 patients aged ≥50 years with type 2 diabetes mellitus (mean age 67.8 ± 9.8 years) underwent brain magnetic resonance imaging scans and comprehensive health examinations. We measured the volume of interest - a portion of the inner temporal lobe that includes the hippocampus, amygdala and entorhinal cortex (frontal part of the parahippocampal gyrus) - using the voxel-based specific regional analysis system for Alzheimer's disease in each patient. The diabetes-related parameters included glycated hemoglobin, fasting plasma glucose, C-peptide (CPR) index (serum CPR / fasting plasma glucose × 100) and duration of diabetes.

Results: The mean glycated hemoglobin was 9.3 ± 2.2%, the median CPR index was 1.29 (interquartile range 0.85-1.74) and the median duration of diabetes was 10 years (interquartile range 3-20 years). The severity score of volume of interest atrophy was >1.0 in 36 patients. Using multivariate logistic regression analysis, we found that age (odds ratio 1.09, 95% confidence interval 1.02-1.15) and CPR index (odds ratio 0.451, 95% confidence interval 0.216-0.940) were significantly associated with HPGA.

Conclusions: Lower insulin secretion was significantly associated with HPGA in patients with type 2 diabetes mellitus. The results of this study support the hypothesis that insulin-signaling abnormalities are involved in the pathophysiology of Alzheimer's disease.

Citing Articles

Sequence of episodic memory-related behavioral and brain-imaging abnormalities in type 2 diabetes.

Hu B, Yu Y, Yu X, Ni M, Cui Y, Cao X Nutr Diabetes. 2025; 15(1):1.

PMID: 39893169 PMC: 11787324. DOI: 10.1038/s41387-025-00359-w.

Association of individual-based morphological brain network alterations with cognitive impairment in type 2 diabetes mellitus.

Shen D, Huang X, Diao Z, Wang J, Wang K, Lu W Front Neurol. 2025; 15():1519397.

PMID: 39850732 PMC: 11754055. DOI: 10.3389/fneur.2024.1519397.

Glucose metabolism and smaller hippocampal volume in elderly people with normal cognitive function.

Shima A, Noguchi-Shinohara M, Shibata S, Usui Y, Tatewaki Y, Thyreau B NPJ Aging. 2024; 10(1):39.

PMID: 39251602 PMC: 11384785. DOI: 10.1038/s41514-024-00164-2.

The changes in cognitive function following bariatric surgery considering the function of gut microbiome.

Kheirvari M, Lacy V, Goudarzi H, Rabienezhad Ganji N, Kamali Ardekani M, Anbara T Obes Pillars. 2023; 3:100020.

PMID: 37990721 PMC: 10662092. DOI: 10.1016/j.obpill.2022.100020.

Associations of Dental Health With the Progression of Hippocampal Atrophy in Community-Dwelling Individuals: The Ohasama Study.

Yamaguchi S, Murakami T, Satoh M, Komiyama T, Ohi T, Miyoshi Y Neurology. 2023; 101(10):e1056-e1068.

PMID: 37407259 PMC: 10491442. DOI: 10.1212/WNL.0000000000207579.

References

Dozza B, Smith M, Perry G, Tabaton M, Strocchi P . Regulation of glycogen synthase kinase-3beta by products of lipid peroxidation in human neuroblastoma cells. J Neurochem. 2004; 89(5):1224-32. DOI: 10.1111/j.1471-4159.2004.02413.x. View

Peila R, Rodriguez B, White L, Launer L . Fasting insulin and incident dementia in an elderly population of Japanese-American men. Neurology. 2004; 63(2):228-33. DOI: 10.1212/01.wnl.0000129989.28404.9b. View

Masaki T, Anan F, Shimomura T, Fujiki M, Saikawa T, Yoshimatsu H . Association between hippocampal volume and serum adiponectin in patients with type 2 diabetes mellitus. Metabolism. 2012; 61(8):1197-200. DOI: 10.1016/j.metabol.2012.01.016. View

Fukazawa R, Hanyu H, Sato T, Shimizu S, Koyama S, Kanetaka H . Subgroups of Alzheimer's disease associated with diabetes mellitus based on brain imaging. Dement Geriatr Cogn Disord. 2013; 35(5-6):280-90. DOI: 10.1159/000348407. View

Ohara T, Hata J, Yoshida D, Mukai N, Nagata M, Iwaki T . Trends in dementia prevalence, incidence, and survival rate in a Japanese community. Neurology. 2017; 88(20):1925-1932. DOI: 10.1212/WNL.0000000000003932. View

Hanger D, Hughes K, Woodgett J, Brion J, Anderton B . Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci Lett. 1992; 147(1):58-62. DOI: 10.1016/0304-3940(92)90774-2. View

Ninomiya T . Diabetes mellitus and dementia. Curr Diab Rep. 2014; 14(5):487. DOI: 10.1007/s11892-014-0487-z. View

Novak V, Milberg W, Hao Y, Munshi M, Novak P, Galica A . Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetes. Diabetes Care. 2013; 37(3):751-9. PMC: 3931384. DOI: 10.2337/dc13-1672. View

Moulton C, Costafreda S, Horton P, Ismail K, Fu C . Meta-analyses of structural regional cerebral effects in type 1 and type 2 diabetes. Brain Imaging Behav. 2015; 9(4):651-62. DOI: 10.1007/s11682-014-9348-2. View

10.

Hanyu H, Hirose D, Fukasawa R, Hatanaka H, Namioka N, Sakurai H . Guidelines for the Clinical Diagnosis of Diabetes Mellitus-Related Dementia. J Am Geriatr Soc. 2015; 63(8):1721-3. DOI: 10.1111/jgs.13581. View

11.

Ke Y, Delerue F, Gladbach A, Gotz J, Ittner L . Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease. PLoS One. 2009; 4(11):e7917. PMC: 2775636. DOI: 10.1371/journal.pone.0007917. View

12.

Jolivalt C, Hurford R, Lee C, Dumaop W, Rockenstein E, Masliah E . Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice. Exp Neurol. 2009; 223(2):422-31. PMC: 2864332. DOI: 10.1016/j.expneurol.2009.11.005. View

13.

Matsuda H, Mizumura S, Nemoto K, Yamashita F, Imabayashi E, Sato N . Automatic voxel-based morphometry of structural MRI by SPM8 plus diffeomorphic anatomic registration through exponentiated lie algebra improves the diagnosis of probable Alzheimer Disease. AJNR Am J Neuroradiol. 2012; 33(6):1109-14. PMC: 8013247. DOI: 10.3174/ajnr.A2935. View

14.

Ronnemaa E, Zethelius B, Sundelof J, Sundstrom J, Degerman-Gunnarsson M, Berne C . Impaired insulin secretion increases the risk of Alzheimer disease. Neurology. 2008; 71(14):1065-71. DOI: 10.1212/01.wnl.0000310646.32212.3a. View

15.

Adachi Y, Ota K, Minami I, Yamada T, Watanabe T . Lower insulin secretion is associated with hippocampal and parahippocampal gyrus atrophy in elderly patients with type 2 diabetes mellitus. J Diabetes Investig. 2021; 12(10):1908-1913. PMC: 8504906. DOI: 10.1111/jdi.13554. View

16.

Lannert H, Hoyer S . Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci. 1998; 112(5):1199-208. DOI: 10.1037//0735-7044.112.5.1199. View

17.

Gomez-Isla T, HOLLISTER R, West H, Mui S, Growdon J, Petersen R . Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol. 1997; 41(1):17-24. DOI: 10.1002/ana.410410106. View

18.

Serbedzija P, Madl J, Ishii D . Insulin and IGF-I prevent brain atrophy and DNA loss in diabetes. Brain Res. 2009; 1303:179-94. PMC: 2828498. DOI: 10.1016/j.brainres.2009.09.063. View

19.

Biessels G, Despa F . Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018; 14(10):591-604. PMC: 6397437. DOI: 10.1038/s41574-018-0048-7. View

20.

Feinkohl I, Price J, Strachan M, Frier B . The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factors. Alzheimers Res Ther. 2015; 7(1):46. PMC: 4460635. DOI: 10.1186/s13195-015-0130-5. View